We have generated multiple lines of transgenic Drosophila model with cardiomyopathy genes respectively, which specifically display myopathy. In this objective, we are using these flies as a whole animal model to screen 2000 FDA approved compounds. In addition, we are exploring the molecular mechanisms of potential candidate drugs that rescue cardiomyopathy.